GAPDHP70

Across TCGA pan-cancer cohorts, GAPDHP70 RNA is linked to patient survival in 23 of 34 cancer types, making it the most broadly survival-associated GAPDHP70 data layer.

The strongest signal is observed in liver hepatocellular carcinoma (LIHC), where higher GAPDHP70 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated GAPDHP70 expression acts as an unfavorable survival marker, although some lineages such as LUSC and KIRC show a favorable association.

LIHC, LGG, and LUSC are the cancer types where GAPDHP70 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LIHC	OS	Median	All	0.712	0.831	<.001	73	view →
LGG	DFS	Median	All	0.666	0.806	<.001	45	view →
LUSC	OS	Quartile	All	0.910	0.692	<.001	36	view →
KIRC	DFS	Median	III,IV	0.617	0.328	.007	26	view →
OV	DFS	Median	IV	0.396	0.216	.006	26	view →
LUAD	DFS	Tertile	II,III,IV	0.283	0.548	.007	22	view →
STAD	OS	Quartile	II,III,IV	0.639	0.921	.009	18	view →
MESO	OS	Quartile	III,IV	0.395	0.702	.016	17	view →
KIRP	DFS	Median	All	0.430	0.770	<.001	15	view →
KICH	OS	Quartile	II,III,IV	0.606	1.000	.023	12	view →
READ	DFS	Quartile	IV	0.741	0.262	.020	11	view →
SKCM	OS	Median	II,III,IV	0.783	0.681	.011	10	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 23 lineages.

GAPDHP70–LIHC (OS)

Open the LIHC breakdown →